SCHEMBL606309

SCHEMBL606309

CC(C)(C)OC(=O)N[C@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.79

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ACE P12821 2/20 0.79
CTSS P25774 3/20 0.70
CTSK P43235 2/20 0.70
CTSL P07711 1/20 0.70
CTSB P07858 1/20 0.70
PPARA Q07869 5/20 0.64
PPARG P37231 4/20 0.64
ITGB3 P05106 1/20 0.62
ITGA2B P08514 1/20 0.62
APP P05067 1/20 0.62
ATM Q13315 2/20 0.61
AKT1 P31749 1/20 0.60
MAPK1 P28482 1/20 0.60
PPARD Q03181 2/20 0.58
KMT2A Q03164 1/20 0.58
PTPN1 P18031 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL795685 1.00 ACE (0.79) ACECTSSCTSKCTSLCTSB
SCHEMBL27909397 1.00 ACE (0.79) ACECTSSCTSKCTSLCTSB
SCHEMBL21473784 1.00 ACE (0.79) ACECTSSCTSKCTSLCTSB
SCHEMBL67020 1.00 ACE (0.79) ACECTSSCTSKCTSLCTSB
SCHEMBL66220 1.00 ACE (0.79) ACECTSSCTSKCTSLCTSB
SCHEMBL29707278 0.98 ACE (0.77) ACECTSSCTSKCTSLCTSB
Water SCHEMBL15362012 0.98 ACE (0.77) ACECTSSCTSKCTSLCTSB
Water SCHEMBL15362013 0.98 ACE (0.77) ACECTSSCTSKCTSLCTSB
SCHEMBL26654474 0.98 ACE (0.77) ACECTSSCTSKCTSLCTSB
SCHEMBL26654472 0.98 ACE (0.77) ACECTSSCTSKCTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1228 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122010833-A Method for catalyzing tension ring heteroaryl by iron 南京师范大学 2026-05-12 CN claimed
CN-118878622-B Green chemical synthesis method of illegal stand 中肽生化有限公司 2026-02-27 CN claimed
CN-119818387-A Application and synthesis method of cyclic peptide 上海中翊日化有限公司 2025-04-15 CN claimed
CN-119798139-A Method for synthesizing phenolic compound by iron-catalyzed hydroxylation reaction of aromatic compound 南京师范大学 2025-04-11 CN claimed
CN-119798062-A Method for catalyzing quinone hydroxylation reaction of alkene by iron 南京师范大学 2025-04-11 CN claimed
CN-119798083-A Iron-catalyzed aromatic compound carbon-hydrogen bond hydroxylation nitration method 南京师范大学 2025-04-11 CN claimed
US-20250019367-A1 Methods for Separation of Enantiomers Mirati Therapeutics, Inc. 2025-01-16 US claimed
CN-116199572-B Method for alpha-bromination of iron-catalyzed ketone 南京师范大学 2025-01-14 CN claimed
CN-115925544-B Method for ring-opening acrylation of tertiary alcohol through iron catalytic oxidation 南京师范大学 2025-01-14 CN claimed
CN-119264009-A Photoisomerization chiral hydrogel material and preparation method and application thereof 河南大学 2025-01-07 CN claimed
US-20140135509-A1 Process for the Preparation of Benzyl [(3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol]-4-yl]carbamate and Intermediates in the Process ASTRAZENECA AB (SE) 2014-05-15 US claimed
EP-2707363-A1 A PROCESS FOR THE PREPARATION OF BENZYL [(3AS,4R,6S,6AR)-6-HYDROXY-2,2- DIMETHYLTETRAHYDRO-3AH-CYCLOPENTA[D][1,3]DIOXOL]-4-YL]CARBAMATE AND INTERMEDIATES IN THE PROCESS AstraZeneca AB (SE) 2014-03-19 EP claimed
CN-103534245-A A process for the preparation of benzyl [(3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol]-4-yl]carbamate and intermediates in the process ASTRAZENECA AB 2014-01-22 CN claimed
WO-2012158099-A1 A PROCESS FOR THE PREPARATION OF BENZYL [(3AS,4R,6S,6AR)-6-HYDROXY-2,2- DIMETHYLTETRAHYDRO-3AH-CYCLOPENTA[D][1,3]DIOXOL]-4-YL]CARBAMATE AND INTERMEDIATES IN THE PROCESS ASTRAZENECA AB (SE) 2012-11-22 WO claimed
US-20120041225-A1 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF VAIDYA NITEEN A (US) 2012-02-16 US claimed
EP-1981831-A2 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF Vaidya, Niteen A. (US) 2008-10-22 EP claimed
CN-101274958-A Bioactive peptide, preparation thereof and application thereof OCEAN UNIV CHINA (CN) 2008-10-01 CN claimed
WO-2007092264-A2 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF VAIDYA NITEEN A (US) 2007-08-16 WO claimed
US-20070185346-A1 Kit for automated resolving agent selection and method thereof VAIDYA NITEEN A 2007-08-09 US claimed
CN-1116424-A Process for producing 3-amino-2-hydroxy-1-propanol derivative KANEKA CORP (JP) 1996-02-07 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250019367-A1 Methods for Separation of Enantiomers PAH, NPEPPS, DNPEP ACE 393/4885CTSS 971/4885CTSK 734/4885
US-20140135509-A1 Process for the Preparation of Benzyl [(3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol]-4-yl]carbamate and Intermediates in the Process CYP4X1, CYP4B1, CBR3 ACE 2967/4885CTSS 824/4885CTSK 1546/4885
US-20120041225-A1 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF ACKR3, KIT, C3AR1 ACE 140/4885CTSS 1371/4885CTSK 1088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.